Provectus Biopharmaceuticals, Inc. (PVCT)

CIK 315545 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Provectus Biopharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Sep 11, 202640001493152-26-042331
Sep 8, 202640001493152-26-041727
Aug 26, 202640001493152-26-040207
Aug 13, 202610-Q0001493152-26-037671
Jul 22, 2026SCHEDULE 13D/A0001493152-26-034217
Jul 2, 202640001493152-26-031718
Jul 1, 20268-K0001493152-26-031379
Jun 30, 202640001493152-26-031402
Jun 30, 202640001493152-26-031403
Jun 30, 202640001493152-26-031404
Jun 22, 20268-K0001493152-26-029512
Jun 18, 20268-K0001493152-26-029280
Jun 5, 202640001493152-26-027467
May 29, 202640001493152-26-026269
May 26, 202640001493152-26-025188
May 15, 202640001493152-26-023486
May 14, 202610-Q0001493152-26-022950
May 7, 202640001493152-26-021663
Apr 30, 2026ARS0001493152-26-019810
Apr 30, 2026DEFA14A0001493152-26-019807
Apr 30, 2026DEF 14A0001493152-26-019805
Apr 29, 202640001493152-26-019644
Apr 21, 20268-K0001493152-26-018160
Apr 20, 2026PRE 14A0001493152-26-018081
Apr 6, 202640001493152-26-015333